Kristie Burns Sells 4,830 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) Stock

Tactile Systems Technology, Inc. (NASDAQ:TCMD) VP Kristie Burns sold 4,830 shares of the stock in a transaction on Monday, February 24th. The stock was sold at an average price of $14.65, for a total value of $70,759.50. Following the sale, the vice president now owns 84,008 shares in the company, valued at $1,230,717.20. The trade was a 5.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Tactile Systems Technology Trading Down 1.0 %

Tactile Systems Technology stock traded down $0.15 during mid-day trading on Monday, hitting $14.90. The stock had a trading volume of 483,839 shares, compared to its average volume of 299,195. The stock has a 50-day simple moving average of $17.26 and a two-hundred day simple moving average of $15.71. The company has a current ratio of 4.36, a quick ratio of 3.80 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $351.42 million, a PE ratio of 21.29 and a beta of 1.20. Tactile Systems Technology, Inc. has a 12 month low of $11.12 and a 12 month high of $21.10.

Tactile Systems Technology (NASDAQ:TCMD) last issued its earnings results on Tuesday, February 18th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.09. Tactile Systems Technology had a net margin of 5.79% and a return on equity of 9.37%. The company had revenue of $85.59 million for the quarter, compared to analyst estimates of $85.39 million. As a group, sell-side analysts forecast that Tactile Systems Technology, Inc. will post 0.7 EPS for the current year.

Hedge Funds Weigh In On Tactile Systems Technology

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Rhumbline Advisers lifted its stake in shares of Tactile Systems Technology by 1.6% in the 4th quarter. Rhumbline Advisers now owns 38,033 shares of the company’s stock valued at $651,000 after purchasing an additional 581 shares during the period. Sterling Capital Management LLC lifted its stake in Tactile Systems Technology by 2.8% in the fourth quarter. Sterling Capital Management LLC now owns 25,028 shares of the company’s stock valued at $429,000 after buying an additional 683 shares during the period. SG Americas Securities LLC lifted its stake in Tactile Systems Technology by 12.7% in the fourth quarter. SG Americas Securities LLC now owns 12,032 shares of the company’s stock valued at $206,000 after buying an additional 1,354 shares during the period. Northern Trust Corp boosted its holdings in Tactile Systems Technology by 0.7% during the fourth quarter. Northern Trust Corp now owns 205,914 shares of the company’s stock worth $3,527,000 after buying an additional 1,371 shares during the last quarter. Finally, Legal & General Group Plc boosted its stake in shares of Tactile Systems Technology by 33.2% during the 4th quarter. Legal & General Group Plc now owns 6,257 shares of the company’s stock worth $107,000 after buying an additional 1,558 shares during the last quarter. 83.43% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. B. Riley downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $23.00 to $18.00 in a research report on Wednesday, February 19th. StockNews.com lowered shares of Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a research report on Thursday, January 16th. Oppenheimer lowered shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 5th. Finally, BTIG Research downgraded Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.